Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126694381 | 12669438 | 1 | I | 201604 | 20160810 | 20160819 | 20160819 | EXP | FR-PFIZER INC-2016382646 | PFIZER | 49.00 | YR | F | Y | 60.50000 | KG | 20160819 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126694381 | 12669438 | 1 | PS | Triflucan | FLUCONAZOLE | 1 | Oral | 200 MG, 1X/DAY | Y | 19949 | 200 | MG | QD | ||||||
| 126694381 | 12669438 | 2 | SS | Amlor | AMLODIPINE BESYLATE | 1 | Oral | 10 MG, 1X/DAY | Y | 19787 | 10 | MG | CAPSULE, HARD | QD | |||||
| 126694381 | 12669438 | 3 | SS | INEXIUM /01479302/ | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, 1X/DAY | Y | 0 | 40 | MG | QD | ||||||
| 126694381 | 12669438 | 4 | SS | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 10 MG, 3X/DAY | Y | 0 | 10 | MG | TID | ||||||
| 126694381 | 12669438 | 5 | SS | DOLIPRANE | ACETAMINOPHEN | 1 | Oral | 1 G, 3X/DAY | Y | 0 | 1 | G | TID | ||||||
| 126694381 | 12669438 | 6 | SS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Oral | 750 MG, 2X/DAY | Y | 0 | 750 | MG | BID | ||||||
| 126694381 | 12669438 | 7 | SS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Oral | 500 MG, 2X/DAY | Y | 0 | 500 | MG | BID | ||||||
| 126694381 | 12669438 | 8 | SS | NULOJIX | BELATACEPT | 1 | Intravenous (not otherwise specified) | 300 MG, SINGLE PER MONTH | Y | 0 | 300 | MG | |||||||
| 126694381 | 12669438 | 9 | SS | ROVALCYTE | VALGANCICLOVIR HYDROCHLORIDE | 1 | Oral | 450 MG, WEEKLY | Y | 0 | 450 | MG | /wk | ||||||
| 126694381 | 12669438 | 10 | C | ATENOLOL ARROW | 2 | Oral | 50 MG, 1X/DAY | 0 | 50 | MG | QD | ||||||||
| 126694381 | 12669438 | 11 | C | SOLUPRED /00016201/ | PREDNISOLONE | 1 | Oral | 17.5 MG, DAILY | 0 | 17.5 | MG | ||||||||
| 126694381 | 12669438 | 12 | C | ARANESP | DARBEPOETIN ALFA | 1 | Subcutaneous | 100 UG, EVERY 2 WEEKS | 0 | 100 | UG | ||||||||
| 126694381 | 12669438 | 13 | C | SODIUM BICARBONATE W/TARTARIC ACID | 2 | Oral | 2 G, 3X/DAY | 0 | 2 | G | TID | ||||||||
| 126694381 | 12669438 | 14 | C | FORLAX | POLYETHYLENE GLYCOL 4000 | 1 | Oral | 1 DF, DAILY | 0 | 1 | DF | ||||||||
| 126694381 | 12669438 | 15 | C | ZOPHREN /00955301/ | ONDANSETRON | 1 | Oral | 4 MG, DAILY | 0 | 4 | MG | ||||||||
| 126694381 | 12669438 | 16 | C | MAGNE B6 /00869101/ | 2 | Oral | 8 DF, DAILY | 0 | 8 | DF |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126694381 | 12669438 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126694381 | 12669438 | Agranulocytosis | |
| 126694381 | 12669438 | Neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126694381 | 12669438 | 1 | 20160429 | 0 | ||
| 126694381 | 12669438 | 2 | 20160430 | 0 | ||
| 126694381 | 12669438 | 3 | 20160430 | 0 | ||
| 126694381 | 12669438 | 4 | 20160430 | 0 | ||
| 126694381 | 12669438 | 5 | 20160430 | 0 | ||
| 126694381 | 12669438 | 6 | 20160330 | 20160423 | 0 | |
| 126694381 | 12669438 | 7 | 20160425 | 0 | ||
| 126694381 | 12669438 | 8 | 20160428 | 20160428 | 0 | |
| 126694381 | 12669438 | 9 | 20160425 | 0 |